
### [MONDO:0019097](http://purl.obolibrary.org/obo/MONDO_0019097)
**Label:** rare hemorrhagic disorder due to a constitutional platelet anomaly

**Subclasses:** [MONDO:0016502](http://purl.obolibrary.org/obo/MONDO_0016502) (Hermansky-Pudlak syndrome without pulmonary fibrosis), [MONDO:0016501](http://purl.obolibrary.org/obo/MONDO_0016501) (Hermansky-Pudlak syndrome with pulmonary fibrosis), [MONDO:0018796](http://purl.obolibrary.org/obo/MONDO_0018796) (isolated constitutional thrombocytopenia), [MONDO:0017057](http://purl.obolibrary.org/obo/MONDO_0017057) (hereditary thrombocytopenia with normal platelets), [MONDO:0009276](http://purl.obolibrary.org/obo/MONDO_0009276) (Bernard-Soulier syndrome), [MONDO:0019138](http://purl.obolibrary.org/obo/MONDO_0019138) (bleeding diathesis due to a collagen receptor defect), [MONDO:0019312](http://purl.obolibrary.org/obo/MONDO_0019312) (Hermansky-Pudlak syndrome), [MONDO:0018795](http://purl.obolibrary.org/obo/MONDO_0018795) (syndromic constitutional thrombocytopenia), [MONDO:0017141](http://purl.obolibrary.org/obo/MONDO_0017141) (rare hemorrhagic disorder due to a constitutional thrombocytopenia), [MONDO:0015372](http://purl.obolibrary.org/obo/MONDO_0015372) (autosomal dominant macrothrombocytopenia), [MONDO:0017142](http://purl.obolibrary.org/obo/MONDO_0017142) (rare hemorrhagic disorder due to a qualitative platelet defect), [MONDO:0016361](http://purl.obolibrary.org/obo/MONDO_0016361) (isolated hereditary giant platelet disorder), [MONDO:0011071](http://purl.obolibrary.org/obo/MONDO_0011071) (hereditary thrombocytopenia with normal platelets-hematological cancer predisposition syndrome), [MONDO:0020117](http://purl.obolibrary.org/obo/MONDO_0020117) (alpha granule disease), [MONDO:0020118](http://purl.obolibrary.org/obo/MONDO_0020118) (dense granule disease), [MONDO:0010518](http://purl.obolibrary.org/obo/MONDO_0010518) (Wiskott-Aldrich syndrome), [MONDO:0007686](http://purl.obolibrary.org/obo/MONDO_0007686) (gray platelet syndrome), [MONDO:0011555](http://purl.obolibrary.org/obo/MONDO_0011555) (radio-ulnar synostosis-amegakaryocytic thrombocytopenia syndrome), [MONDO:0015679](http://purl.obolibrary.org/obo/MONDO_0015679) (autosomal thrombocytopenia with normal platelets), [MONDO:0011603](http://purl.obolibrary.org/obo/MONDO_0011603) (GNE myopathy), [MONDO:0015912](http://purl.obolibrary.org/obo/MONDO_0015912) (MYH-9 related disease), 

**Corr. equiv. classes:** [OMIM:605432](http://purl.obolibrary.org/obo/OMIM_605432), [OMIM:601399](http://purl.obolibrary.org/obo/OMIM_601399), [Orphanet:231500](http://www.orpha.net/ORDO/Orphanet_231500), [Orphanet:477794](http://www.orpha.net/ORDO/Orphanet_477794), [Orphanet:477797](http://www.orpha.net/ORDO/Orphanet_477797), [OMIM:139090](http://purl.obolibrary.org/obo/OMIM_139090), [Orphanet:220452](http://www.orpha.net/ORDO/Orphanet_220452), [Orphanet:182050](http://www.orpha.net/ORDO/Orphanet_182050), [Orphanet:168629](http://www.orpha.net/ORDO/Orphanet_168629), [OMIM:231200](http://purl.obolibrary.org/obo/OMIM_231200), [Orphanet:79430](http://www.orpha.net/ORDO/Orphanet_79430), [Orphanet:98455](http://www.orpha.net/ORDO/Orphanet_98455), [Orphanet:98456](http://www.orpha.net/ORDO/Orphanet_98456), [OMIM:301000](http://purl.obolibrary.org/obo/OMIM_301000), [Orphanet:73271](http://www.orpha.net/ORDO/Orphanet_73271), [Orphanet:274](http://www.orpha.net/ORDO/Orphanet_274), [OMIM:605820](http://purl.obolibrary.org/obo/OMIM_605820), [Orphanet:71290](http://www.orpha.net/ORDO/Orphanet_71290), [Orphanet:231512](http://www.orpha.net/ORDO/Orphanet_231512), [Orphanet:140957](http://www.orpha.net/ORDO/Orphanet_140957), [Orphanet:275729](http://www.orpha.net/ORDO/Orphanet_275729), [Orphanet:268322](http://www.orpha.net/ORDO/Orphanet_268322), [Orphanet:275736](http://www.orpha.net/ORDO/Orphanet_275736), [Orphanet:906](http://www.orpha.net/ORDO/Orphanet_906), [Orphanet:71289](http://www.orpha.net/ORDO/Orphanet_71289), [Orphanet:602](http://www.orpha.net/ORDO/Orphanet_602), [OMIM:277970](http://purl.obolibrary.org/obo/OMIM_277970), [Orphanet:721](http://www.orpha.net/ORDO/Orphanet_721), 

**Class expressions from DL-Learner:**

- [HP:0000421](http://purl.obolibrary.org/obo/HP_0000421) (Epistaxis) and [HP:0001872](http://purl.obolibrary.org/obo/HP_0001872) (Abnormality of thrombocytes) 54.33%
- [HP:0000421](http://purl.obolibrary.org/obo/HP_0000421) (Epistaxis) and [HP:0001872](http://purl.obolibrary.org/obo/HP_0001872) (Abnormality of thrombocytes) and [HP:0011354](http://purl.obolibrary.org/obo/HP_0011354) (Generalized abnormality of skin) 54.33%
- [HP:0000421](http://purl.obolibrary.org/obo/HP_0000421) (Epistaxis) and [HP:0001872](http://purl.obolibrary.org/obo/HP_0001872) (Abnormality of thrombocytes) and [HP:0011276](http://purl.obolibrary.org/obo/HP_0011276) (Vascular skin abnormality) 54.33%
- [HP:0000421](http://purl.obolibrary.org/obo/HP_0000421) (Epistaxis) and [HP:0001872](http://purl.obolibrary.org/obo/HP_0001872) (Abnormality of thrombocytes) and [HP:0011121](http://purl.obolibrary.org/obo/HP_0011121) (Abnormality of skin morphology) 54.33%
- [HP:0000421](http://purl.obolibrary.org/obo/HP_0000421) (Epistaxis) and [HP:0001872](http://purl.obolibrary.org/obo/HP_0001872) (Abnormality of thrombocytes) and [HP:0002597](http://purl.obolibrary.org/obo/HP_0002597) (Abnormality of the vasculature) 54.33%
- [HP:0000421](http://purl.obolibrary.org/obo/HP_0000421) (Epistaxis) and [HP:0001872](http://purl.obolibrary.org/obo/HP_0001872) (Abnormality of thrombocytes) and [HP:0001933](http://purl.obolibrary.org/obo/HP_0001933) (Subcutaneous hemorrhage) 54.33%
- [HP:0000421](http://purl.obolibrary.org/obo/HP_0000421) (Epistaxis) and [HP:0001626](http://purl.obolibrary.org/obo/HP_0001626) (Abnormality of the cardiovascular system) and [HP:0001872](http://purl.obolibrary.org/obo/HP_0001872) (Abnormality of thrombocytes) 54.33%
- [HP:0000421](http://purl.obolibrary.org/obo/HP_0000421) (Epistaxis) and [HP:0001574](http://purl.obolibrary.org/obo/HP_0001574) (Abnormality of the integument) and [HP:0001872](http://purl.obolibrary.org/obo/HP_0001872) (Abnormality of thrombocytes) 54.33%
- [HP:0000421](http://purl.obolibrary.org/obo/HP_0000421) (Epistaxis) and [HP:0000951](http://purl.obolibrary.org/obo/HP_0000951) (Abnormality of the skin) and [HP:0001872](http://purl.obolibrary.org/obo/HP_0001872) (Abnormality of thrombocytes) 54.33%
- [HP:0000421](http://purl.obolibrary.org/obo/HP_0000421) (Epistaxis) and [HP:0001872](http://purl.obolibrary.org/obo/HP_0001872) (Abnormality of thrombocytes) and [HP:0002597](http://purl.obolibrary.org/obo/HP_0002597) (Abnormality of the vasculature) and [HP:0011354](http://purl.obolibrary.org/obo/HP_0011354) (Generalized abnormality of skin) 54.33%
- [HP:0000421](http://purl.obolibrary.org/obo/HP_0000421) (Epistaxis) and [HP:0001872](http://purl.obolibrary.org/obo/HP_0001872) (Abnormality of thrombocytes) and [HP:0002597](http://purl.obolibrary.org/obo/HP_0002597) (Abnormality of the vasculature) and [HP:0011121](http://purl.obolibrary.org/obo/HP_0011121) (Abnormality of skin morphology) 54.33%
- [HP:0000421](http://purl.obolibrary.org/obo/HP_0000421) (Epistaxis) and [HP:0001626](http://purl.obolibrary.org/obo/HP_0001626) (Abnormality of the cardiovascular system) and [HP:0001872](http://purl.obolibrary.org/obo/HP_0001872) (Abnormality of thrombocytes) and [HP:0011354](http://purl.obolibrary.org/obo/HP_0011354) (Generalized abnormality of skin) 54.33%
- [HP:0000421](http://purl.obolibrary.org/obo/HP_0000421) (Epistaxis) and [HP:0001626](http://purl.obolibrary.org/obo/HP_0001626) (Abnormality of the cardiovascular system) and [HP:0001872](http://purl.obolibrary.org/obo/HP_0001872) (Abnormality of thrombocytes) and [HP:0011121](http://purl.obolibrary.org/obo/HP_0011121) (Abnormality of skin morphology) 54.33%
- [HP:0000421](http://purl.obolibrary.org/obo/HP_0000421) (Epistaxis) and [HP:0001574](http://purl.obolibrary.org/obo/HP_0001574) (Abnormality of the integument) and [HP:0001872](http://purl.obolibrary.org/obo/HP_0001872) (Abnormality of thrombocytes) and [HP:0002597](http://purl.obolibrary.org/obo/HP_0002597) (Abnormality of the vasculature) 54.33%
- [HP:0000421](http://purl.obolibrary.org/obo/HP_0000421) (Epistaxis) and [HP:0001574](http://purl.obolibrary.org/obo/HP_0001574) (Abnormality of the integument) and [HP:0001626](http://purl.obolibrary.org/obo/HP_0001626) (Abnormality of the cardiovascular system) and [HP:0001872](http://purl.obolibrary.org/obo/HP_0001872) (Abnormality of thrombocytes) 54.33%


